Skip to main content
Home
  • FÜR INVESTOREN
  • FÜR KLINIKER
  • News & Events
  • STARTSEITE
  • ÜBER REACTIV8
  • Über Mainstay
  • Careers
  • Contact
  • EN
  • FR
  • DE
  • NL
  • US
  • AU
Sub menu▸
  • OVERVIEW
  • Results and Presentations
  • News
  • Governance
    • Corporate Governance
    • Board of Directors
    • Leadership Team
    • Board Committees
    • AGM
    • Documents relating to proposed delisting transaction and related shareholder meetings on 8 May
    • Documents relating to February 2021 EGM
  • Shareholder Information
  • Contact Us

Documents relating to proposed delisting transaction and related shareholder meetings on 8 May

Date
Title
  • 26 May 2020
    Advertisement of Court Hearing
  • 14 Apr 2020
    Mainstay PLC Memorandum and Articles
  • 14 Apr 2020
    Mainstay Holdings Memorandum and Articles
  • 14 Apr 2020
    Mainstay plc Memorandum and Articles vs. the Mainstay Holdings Memorandum and Articles
  • 14 Apr 2020
    EGM Proxy Form
  • 14 Apr 2020
    Scheme Proxy Form
  • 14 Apr 2020
    Voting undertaking from IPF
  • 14 Apr 2020
    The Circular

© Copyright 2020 Mainstay Medical Limited. Alle Rechte vorbehalten.

Footer menu

  • Plan der Website
  • Kontakt
  • Impressum
  • Datenschutz
  • Nutzungsbedingungen
  • Commercial Terms & Conditions

ReActiv8 ist für die Behandlung von chronischem unterem Rückenschmerz CE zertifiziert und ist in Europa für den Verkauf verfügbar.

Disclaimer

I am in the United States, Canada, Japan or Australia.

Show